abstract |
The present invention provides a compound having the structure ##STR1## wherein, R 1 , R 2 , R 3 , R 4 and R 5 are independently selected from H, alkyl, aminoalkyl, perfluoroalkyl, or n pharmaceutically acceptable salts thereof, useful for treating cancer. |